135 results on '"Taivassalo T"'
Search Results
2. P134 Energetics and acid-base status of skeletal muscle at rest and following isometric dorsiflexion and plantar flexion contractions in Duchenne muscular dystrophy
- Author
-
Awale, P., primary, Lopez, C., additional, Taivassalo, T., additional, Vandenborne, K., additional, Walter, G., additional, and Forbes, S., additional
- Published
- 2023
- Full Text
- View/download PDF
3. Applications of magnetic resonance spectroscopy to diagnosis and monitoring of mitochondrial disease
- Author
-
Matthews P. M. and Taivassalo T.
- Published
- 1997
- Full Text
- View/download PDF
4. EFFECT OF ENDURANCE TRAINING ON NUCLEAR-ENCODED MITOCHONDRIAL PROTEINS IN PATIENTS WITH MTDNA DEFECTS
- Author
-
Adhihetty, P J., Taivassalo, T, Haller, R G., and Hood, D A.
- Published
- 2003
5. OXYGEN PULSE DURING CYCLE EXERCISE IN MITOCHONDRIAL MYOPATHY
- Author
-
Wyrick, P S., Taivassalo, T, and Haller, R G.
- Published
- 2003
6. RESISTANCE EXERCISE TRAINING FOR MITOCHONDRIAL MYOPATHIES: EFFECTS ON MUSCLE STRENGTH AND MITOCHONDRIAL FUNCTION
- Author
-
Taivassalo, T, Shoubridge, E, Wyrick, P, Lofberg, M, and Haller, R G.
- Published
- 2002
7. Common data elements for clinical research in mitochondrial disease: a National Institute for Neurological Disorders and Stroke project
- Author
-
Karaa, A., Rahman, S., Lombes, A., Yu-Wai-Man, P., Sheikh, M.K., Alai-Hansen, S., Cohen, B.H., Dimmock, D., Emrick, L., Falk, M.J., McCormack, S., Mirsky, D., Moore, T., Parikh, S., Shoffner, J., Taivassalo, T., Tarnopolsky, M., Tein, I., Odenkirchen, J.C., Goldstein, A., Koene, S., Smeitink, J.A.M., Karaa, Amel, Rahman, Shamima, Lombès, Anne, Yu-Wai-Man, Patrick, Sheikh, Muniza K., Alai-Hansen, Sherita, Cohen, Bruce H., Dimmock, David, Emrick, Lisa, Falk, Marni J., Mccormack, Shana, Mirsky, David, Moore, Tony, Parikh, Sumit, Shoffner, John, Taivassalo, Tanja, Tarnopolsky, Mark, Tein, Ingrid, Odenkirchen, Joanne C., Goldstein, Amy, Mito Working Group, and Carelli Valerio
- Subjects
0301 basic medicine ,Gerontology ,Research design ,medicine.medical_specialty ,Mitochondrial Diseases ,Biomedical Research ,Mitochondrial disease ,Clinical Sciences ,MEDLINE ,03 medical and health sciences ,0302 clinical medicine ,Genetic ,Genetics ,medicine ,Humans ,National Institute of Neurological Disorders and Stroke (U.S.) ,Stroke ,Genetics (clinical) ,Genetics & Heredity ,Common Data Elements ,Extramural ,business.industry ,Data Collection ,Metabolic Disorders Radboud Institute for Health Sciences [Radboudumc 6] ,Neurosciences ,Metabolic Disorders Radboud Institute for Molecular Life Sciences [Radboudumc 6] ,medicine.disease ,United States ,Brain Disorders ,030104 developmental biology ,Clinical research ,Research Design ,Family medicine ,Data quality ,Research studies ,[Mito Working Group Member Participants] ,Nervous System Diseases ,business ,030217 neurology & neurosurgery - Abstract
Contains fulltext : 174061.pdf (Publisher’s version ) (Closed access) OBJECTIVES: The common data elements (CDE) project was developed by the National Institute of Neurological Disorders and Stroke (NINDS) to provide clinical researchers with tools to improve data quality and allow for harmonization of data collected in different research studies. CDEs have been created for several neurological diseases; the aim of this project was to develop CDEs specifically curated for mitochondrial disease (Mito) to enhance clinical research. METHODS: Nine working groups (WGs), composed of international mitochondrial disease experts, provided recommendations for Mito clinical research. They initially reviewed existing NINDS CDEs and instruments, and developed new data elements or instruments when needed. Recommendations were organized, internally reviewed by the Mito WGs, and posted online for external public comment for a period of eight weeks. The final version was again reviewed by all WGs and the NINDS CDE team prior to posting for public use. RESULTS: The NINDS Mito CDEs and supporting documents are publicly available on the NINDS CDE website ( https://commondataelements.ninds.nih.gov/ ), organized into domain categories such as Participant/Subject Characteristics, Assessments, and Examinations. CONCLUSION: We developed a comprehensive set of CDE recommendations, data definitions, case report forms (CRFs), and guidelines for use in Mito clinical research. The widespread use of CDEs is intended to enhance Mito clinical research endeavors, including natural history studies, clinical trial design, and data sharing. Ongoing international collaboration will facilitate regular review, updates and online publication of Mito CDEs, and support improved consistency of data collection and reporting.
- Published
- 2017
8. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease
- Author
-
Maltais, F., Decramer, M., Casaburi, R., Barreiro, E., Burelle, Y., Debigare, R., Dekhuijzen, P.N.R., Franssen, F., Gayan-Ramirez, G., Gea, J., Gosker, H.R., Gosselink, R., Hayot, M., Hussain, S.N., Janssens, W., Polkey, M.I., Roca, J., Saey, D., Schols, A.M.W.J., Spruit, M.A., Steiner, M., Taivassalo, T., Troosters, T., Vogiatzis, I., Wagner, P.D., et al., Maltais, F., Decramer, M., Casaburi, R., Barreiro, E., Burelle, Y., Debigare, R., Dekhuijzen, P.N.R., Franssen, F., Gayan-Ramirez, G., Gea, J., Gosker, H.R., Gosselink, R., Hayot, M., Hussain, S.N., Janssens, W., Polkey, M.I., Roca, J., Saey, D., Schols, A.M.W.J., Spruit, M.A., Steiner, M., Taivassalo, T., Troosters, T., Vogiatzis, I., Wagner, P.D., and et al.
- Abstract
Item does not contain fulltext, BACKGROUND: Limb muscle dysfunction is prevalent in chronic obstructive pulmonary disease (COPD) and it has important clinical implications, such as reduced exercise tolerance, quality of life, and even survival. Since the previous American Thoracic Society/European Respiratory Society (ATS/ERS) statement on limb muscle dysfunction, important progress has been made on the characterization of this problem and on our understanding of its pathophysiology and clinical implications. PURPOSE: The purpose of this document is to update the 1999 ATS/ERS statement on limb muscle dysfunction in COPD. METHODS: An interdisciplinary committee of experts from the ATS and ERS Pulmonary Rehabilitation and Clinical Problems assemblies determined that the scope of this document should be limited to limb muscles. Committee members conducted focused reviews of the literature on several topics. A librarian also performed a literature search. An ATS methodologist provided advice to the committee, ensuring that the methodological approach was consistent with ATS standards. RESULTS: We identified important advances in our understanding of the extent and nature of the structural alterations in limb muscles in patients with COPD. Since the last update, landmark studies were published on the mechanisms of development of limb muscle dysfunction in COPD and on the treatment of this condition. We now have a better understanding of the clinical implications of limb muscle dysfunction. Although exercise training is the most potent intervention to address this condition, other therapies, such as neuromuscular electrical stimulation, are emerging. Assessment of limb muscle function can identify patients who are at increased risk of poor clinical outcomes, such as exercise intolerance and premature mortality. CONCLUSIONS: Limb muscle dysfunction is a key systemic consequence of COPD. However, there are still important gaps in our knowledge about the mechanisms of development of this problem. Strategie
- Published
- 2014
9. Autophagy in locomotor muscles of patients with chronic obstructive pulmonary disease
- Author
-
Guo, Y., Guo, Y., Gosker, H.R., Schols, A.M.W.J., Kapchinsky, S., Bourbeau, J., Sandri, M., Jagoe, R.T., Debigare, R., Maltais, F., Taivassalo, T., Hussain, S.N., Guo, Y., Guo, Y., Gosker, H.R., Schols, A.M.W.J., Kapchinsky, S., Bourbeau, J., Sandri, M., Jagoe, R.T., Debigare, R., Maltais, F., Taivassalo, T., and Hussain, S.N.
- Abstract
Rationale: Locomotor muscle atrophy develops in patients with chronic obstructive pulmonary disease (COPD) partly because of increased protein degradation by the ubiquitin-proteasome system. It is not known if autophagy also contributes to protein degradation. Objectives: To investigate whether autophagy is enhanced in locomotor muscles of stable patients with COPD, to quantify autophagy-related gene expression in these muscles, and to identify mechanisms of autophagy induction. Methods: Muscle biopsies were obtained from two cohorts of control subjects and patients with COPD and the numbers of autophagosomes in the vastus lateralis and tibialis anterior muscles, the levels of LC3B protein lipidation, and the expression of autophagy-related genes were measured in the vastus lateralis muscle. To investigate potential pathways that might induce the activation of autophagy, measures were taken of protein kinase B (AKT), mTORC1, and AMPK pathway activation, transcription factor regulation, proteasome activation, and oxidative stress. Measurements and Main Results: Autophagy is enhanced in the locomotor muscles of patients with COPD as shown by significantly higher numbers of autophagosomes in affected muscles as compared with control subjects. Autophagosome number inversely correlates with FEV1. In the vastus lateralis, LC3B protein lipidation is increased by COPD and the expression of autophagy-related gene expressions is up-regulated. LC3B lipidation inversely correlates with thigh cross-sectional area, FEV1, and FEV1/FVC ratio. Enhanced autophagy is associated with activation of the AMPK pathway and FOXO transcription factors, inhibition of the mTORC1 and AKT pathways, and the development of oxidative stress. Conclusions: Autophagy is significantly enhanced in locomotor muscles of stable patients with COPD. The degree of autophagy correlates with severity of muscle atrophy and lung function impairment.
- Published
- 2013
10. Effect of changes in fat availability on exercise capacity in McArdle disease
- Author
-
Andersen, S.T., Jeppesen, T.D., Taivassalo, T., Sveen, M.L., Heinicke, K., Haller, R.G., Vissing, J., Andersen, S.T., Jeppesen, T.D., Taivassalo, T., Sveen, M.L., Heinicke, K., Haller, R.G., and Vissing, J.
- Abstract
BACKGROUND: The major fuel for exercising muscle at low exercise intensities is fat. OBJECTIVE: To investigate the role of fat metabolism in McArdle disease (also known as glycogen storage disease type V), an inborn error of muscle glycogenolysis, by manipulating free fatty acid availability for oxidation during exercise. DESIGN: Randomized, placebo-controlled, crossover trial. SETTING: Hospitalized care. PATIENTs: Ten patients (8 men and 2 women) with McArdle disease. INTERVENTIONS: Patients cycled at a constant workload corresponding to 70% of their maximum oxygen consumption. In random order and on separate days, patients received nicotinic acid (a known blocker of lipolysis) to decrease the availability of free fatty acids or 20% Intralipid infusion to increase free fatty acid availability during exercise. Results were compared with placebo (isotonic sodium chloride solution infusion) and glucose infusion trials. MAIN OUTCOME MEASURES: Exercise tolerance was assessed by heart rate response to exercise during different infusions. RESULTS: Free fatty acid levels more than tripled by Intralipid infusion and were halved by nicotinic acid administration. Heart rate was significantly higher during exercise in the Intralipid infusion and nicotinic acid trials compared with the placebo and glucose infusion trials, an effect that was observed before and after the patients had experienced the second wind phenomenon. CONCLUSIONS: Lipids are an important source of fuel for exercising muscle in McArdle disease, but maximal rates of fat oxidation seem limited and cannot be increased above physiologically normal rates during exercise. This limitation is probably caused by a metabolic bottleneck in the tricarboxylic acid cycle due to impaired glycolytic flux in McArdle disease. Therapies aimed at enhancing fat use in McArdle disease should be combined with interventions targeting expansion of the tricarboxylic acid cycle Udgivelsesdato: 2009/6
- Published
- 2009
11. Fat metabolism during exercise in patients with McArdle disease
- Author
-
Ørngreen, M C, Jeppesen, T D, Andersen, S Tvede, Taivassalo, T, Hauerslev, S, Preisler, N, Haller, R G, Van Hall, Gerrit, Vissing, J, Ørngreen, M C, Jeppesen, T D, Andersen, S Tvede, Taivassalo, T, Hauerslev, S, Preisler, N, Haller, R G, Van Hall, Gerrit, and Vissing, J
- Abstract
Udgivelsesdato: 2009-Feb-24, OBJECTIVE: It is known that muscle phosphorylase deficiency restricts carbohydrate utilization, but the implications for muscle fat metabolism have not been studied. We questioned whether patients with McArdle disease can compensate for the blocked muscle glycogen breakdown by enhancing fat oxidation during exercise. METHODS: We studied total fat oxidation by indirect calorimetry and palmitate turnover by stable isotope methodology in 11 patients with McArdle disease and 11 healthy controls. Cycle exercise at a constant workload of 50% to 60% of maximal oxygen uptake capacity was used to evaluate fatty acid oxidation (FAO) in the patients. Healthy controls were exercised at the same absolute workload. RESULTS: We found that palmitate oxidation and disposal, total fat oxidation, and plasma levels of palmitate and total free fatty acids (FFAs) were significantly higher, whereas total carbohydrate oxidation was lower, during exercise in patients with McArdle disease vs healthy controls. We found augmented fat oxidation with the onset of a second wind, but further increases in FFA availability, as exercise continued, did not result in further increases in FAO. CONCLUSION: These results indicate that patients with McArdle disease have exaggerated fat oxidation during prolonged, low-intensity exercise and that increased fat oxidation may be an important mechanism of the spontaneous second wind. The fact that increasing availability of free fatty acids with more prolonged exercise did not increase fatty acid oxidation suggests that blocked glycogenolysis may limit the capacity of fat oxidation to compensate for the energy deficit in McArdle disease.
- Published
- 2009
12. P62 Long term endurance training and deconditioning in patients with mitochondrial myopathy
- Author
-
Murphy, J.L., primary, Ratnaike, T.E., additional, Shang, E., additional, Falkous, G., additional, Blakely, E.L., additional, Alston, C.L., additional, Hickman, K., additional, Chanter, H., additional, Taivassalo, T., additional, Haller, R.G., additional, Taylor, R.W., additional, and Turnbull, D.M., additional
- Published
- 2012
- Full Text
- View/download PDF
13. P50 Exercise training in patients with mitochondrial myopathy: the analysis of COX-intermediate fibres
- Author
-
Murphy, J.L., primary, Shang, E., additional, Taivassalo, T., additional, Haller, R.G., additional, Taylor, R.W., additional, and Turnbull, D.M., additional
- Published
- 2011
- Full Text
- View/download PDF
14. Fat metabolism during exercise in patients with McArdle disease
- Author
-
Ørngreen, M. C., primary, Jeppesen, T. D., additional, Andersen, S. Tvede, additional, Taivassalo, T., additional, Hauerslev, S., additional, Preisler, N., additional, Haller, R. G., additional, van Hall, G., additional, and Vissing, J., additional
- Published
- 2009
- Full Text
- View/download PDF
15. Resistance training in patients with single, large-scale deletions of mitochondrial DNA
- Author
-
Murphy, J. L., primary, Blakely, E. L., additional, Schaefer, A. M., additional, He, L., additional, Wyrick, P., additional, Haller, R. G., additional, Taylor, R. W., additional, Turnbull, D. M., additional, and Taivassalo, T., additional
- Published
- 2008
- Full Text
- View/download PDF
16. M.P.3.08 Resistance exercise training in mitochondrial myopathy due to single, large-scale deletions: Implications for therapy
- Author
-
Taivassalo, T., primary, Gardner, J., additional, Taylor, R., additional, Schaefer, A., additional, Haller, R., additional, and Taylor, D., additional
- Published
- 2007
- Full Text
- View/download PDF
17. M.P.3.11 Aconitase deficiency in mitochondrial myopathy: An index of oxidative stress
- Author
-
Haller, R., primary, Gunder, M., additional, Heinicke, K., additional, and Taivassalo, T., additional
- Published
- 2007
- Full Text
- View/download PDF
18. Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions
- Author
-
Taivassalo, T., primary, Gardner, J. L., additional, Taylor, R. W., additional, Schaefer, A. M., additional, Newman, J., additional, Barron, M. J., additional, Haller, R. G., additional, and Turnbull, D. M., additional
- Published
- 2006
- Full Text
- View/download PDF
19. The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients
- Author
-
Taivassalo, T., primary
- Published
- 2003
- Full Text
- View/download PDF
20. Modeling in vivo recovery of intracellular pH in muscle to provide a novel index of proton handling: Application to the diagnosis of mitochondrial myopathy
- Author
-
Chen, J.T., primary, Taivassalo, T., additional, Argov, Z., additional, and Arnold, D.L., additional
- Published
- 2001
- Full Text
- View/download PDF
21. Recurrent myoglobinuria due to a nonsense mutation in the COX I gene of mitochondrial DNA
- Author
-
Karadimas, C. L., primary, Greenstein, P., additional, Sue, C. M., additional, Joseph, J. T., additional, Tanji, K., additional, Haller, R. G., additional, Taivassalo, T., additional, Davidson, M. M., additional, Shanske, S., additional, Bonilla, E., additional, and DiMauro, S., additional
- Published
- 2000
- Full Text
- View/download PDF
22. Short-term aerobic training response in chronic myopathies
- Author
-
Taivassalo, T., primary, De Stefano, N., additional, Chen, J., additional, Karpati, G., additional, Arnold, D.L., additional, and Argov, Z., additional
- Published
- 1999
- Full Text
- View/download PDF
23. Gene shifting: a novel therapy for mitochondrial myopathy
- Author
-
Taivassalo, T, primary
- Published
- 1999
- Full Text
- View/download PDF
24. Effects of aerobic training in patients with mitochondrial myopathies
- Author
-
Taivassalo, T., primary, De Stefano, N., additional, Argov, Z., additional, Matthews, P. M., additional, Chen, J., additional, Genge, A., additional, Karpati, G., additional, and Arnold, D. L., additional
- Published
- 1998
- Full Text
- View/download PDF
25. GREATER PERIPHERAL THAN CENTRAL ADAPTATION TO AEROBIC TRAINING IN MITOCHONDRIAL MYOPATHIES 186
- Author
-
Taivassalo, T., primary, De Stefano, N., additional, Argov, Z., additional, Genge, A., additional, Karpati, G., additional, and Arnold, D., additional
- Published
- 1997
- Full Text
- View/download PDF
26. Abnormal oxidative metabolism in exercise in exercise intolerance of undetermined origin
- Author
-
Argov, Z., primary, De Stefano, N., additional, Taivassalo, T., additional, Chen, J., additional, Karpati, G., additional, and Arnold, D.L., additional
- Published
- 1997
- Full Text
- View/download PDF
27. Combined aerobic training and dichloroacetate improve exercise capacity and indices of aerobic metabolism in muscle cytochrome oxidase deficiency
- Author
-
Taivassalo, T., primary, Matthews, P. M., additional, De Stefano, N., additional, Sripathi, N., additional, Genge, A., additional, Karpati, G., additional, and Arnold, D. L., additional
- Published
- 1996
- Full Text
- View/download PDF
28. The mitochondrial phenotype of peripheral muscle in chronic obstructive pulmonary disease: disuse or dysfunction?
- Author
-
Picard M, Godin R, Sinnreich M, Baril J, Bourbeau J, Perrault H, Taivassalo T, and Burelle Y
- Abstract
RATIONALE: Peripheral muscle alterations have been recognized to contribute to disability in chronic obstructive pulmonary disease (COPD). Objectives: To describe the mitochondrial phenotype in a moderate to severe COPD population and age-matched controls. METHODS: Three primary aspects of mitochondrial function were assessed in permeabilized locomotor muscle fibers. MEASUREMENTS AND MAIN RESULTS: Respiration rates per milligram of fiber weight were significantly lower in COPD muscle compared with healthy age-matched control muscle under various respiratory states. However, when variations in mitochondrial volume were taken into account by normalizing respiration per unit of citrate synthase activity, differences between the two groups were abolished, suggesting the absence of specific mitochondrial respiratory impairment in COPD. H(2)O(2) production per mitochondrion was higher both under basal and ADP-stimulated states, suggesting that mitochondria from COPD muscle have properties that potentiate H(2)O(2) release. Direct assessment of mitochondrial sensitivity to Ca(2+)-induced opening of the permeability transition pore (PTP) indicated that mitochondria from patients with COPD were more resistant to PTP opening than their counterparts in control subjects. CONCLUSIONS: Comparison of these results with those of studies comparing healthy glycolytic with oxidative muscle suggests that these differences may be attributable to greater type II fiber expression in COPD muscle, as mitochondria within this fiber type have respiratory function similar to that of mitochondria from type I fibers, and yet are intrinsically prone to greater release of H(2)O(2) and more resistant to PTP opening. These results thus argue against the presence of pathological mitochondrial alterations in this category of patients with COPD. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
29. Aerobic conditioning: An effective therapy in McArdle's disease.
- Author
-
Haller RG, Wyrick P, Taivassalo T, and Vissing J
- Published
- 2006
30. Aerobic conditioning in patients with mitochondrial myopathies: physiological, biochemical, and genetic effects.
- Author
-
Taivassalo, Tanja, Shoubridge, Eric A., Chen, Jacqueline, Kennaway, Nancy G., DiMauro, Salvatore, Arnold, Douglas L., Haller, Ronald G., Taivassalo, T, Shoubridge, E A, Chen, J, Kennaway, N G, DiMauro, S, Arnold, D L, and Haller, R G
- Published
- 2001
- Full Text
- View/download PDF
31. Muscle phosphorus magnetic resonance spectroscopy oxidative indices correlate with physical activity.
- Author
-
Tartaglia, M. Carmela, Chen, Jacqueline T., Caramanos, Zografos, Taivassalo, Tanja, Arnold, Douglas L., Argov, Zohar, Tartaglia, M C, Chen, J T, Caramanos, Z, Taivassalo, T, Arnold, D L, and Argov, Z
- Published
- 2000
- Full Text
- View/download PDF
32. Abnormal oxidative metabolism in exercise intolerance of undetermined origin
- Author
-
Argov, Z., Stefano, N. De, Taivassalo, T., Chen, J., Karpati, G., and Arnold, D. L.
- Published
- 1997
- Full Text
- View/download PDF
33. Intracellular phosphates in inclusion body myositis--a 31P magnetic resonance spectroscopy study.
- Author
-
Argov, Zohar, Taivassalo, Tanja, De Stefano, Nicola, Genge, Angela, Karpati, George, Arnold, Douglas L., Argov, Z, Taivassalo, T, De Stefano, N, Genge, A, Karpati, G, and Arnold, D L
- Published
- 1998
- Full Text
- View/download PDF
34. Resting-state Functional Connectivity of the Motor and Cognitive Areas is Preserved in Masters Athletes.
- Author
-
Potvin-Desrochers A, Atri A, Clouette J, Hepple RT, Taivassalo T, and Paquette C
- Subjects
- Humans, Male, Aged, Female, Middle Aged, Aging physiology, Neural Pathways physiology, Neural Pathways diagnostic imaging, Brain Mapping, Athletes, Magnetic Resonance Imaging, Cognition physiology, Rest physiology, Brain physiology, Brain diagnostic imaging
- Abstract
Aging is characterized by a decline in physical and cognitive functions, often resulting in decreased quality of life. Physical activity has been suggested to potentially slow down various aspects of the aging process, a theory that has been supported by studies of Masters Athletes (MA). For example, MA usually have better cognitive and physical functions than age-matched sedentary and healthy older adults (OA), making them a valuable model to gain insights into mechanisms that promote physical and cognitive function with aging. The purpose of this study was to identify differences in resting-state functional connectivity (rs-FC) of motor and cognitive regions between MA and OA and determine if these differences in the resting brain are associated with differences in cognitive and physical performance between groups. Fifteen MA (9 males) and 12 age-matched OA (six males) were included. rs-FC images were compared to identify significant between-groups differences in brain connectivity. There was higher connectivity between the cognitive and motor networks for the OA group, whereas the MA group had stronger connectivity between different regions within the same network, both for the cognitive and the motor networks. These results are in line with the literature suggesting that aging reduces the segregation between functional networks and causes regions within the same network to be less strongly connected. High-level physical activity practiced by the MA most likely contributes to attenuating aging-related changes in brain functional connectivity, preserving clearer boundaries between different functional networks, which may ultimately favor maintenance of efficient cognitive and sensorimotor processing., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
35. OxPhos defects cause hypermetabolism and reduce lifespan in cells and in patients with mitochondrial diseases.
- Author
-
Sturm G, Karan KR, Monzel AS, Santhanam B, Taivassalo T, Bris C, Ware SA, Cross M, Towheed A, Higgins-Chen A, McManus MJ, Cardenas A, Lin J, Epel ES, Rahman S, Vissing J, Grassi B, Levine M, Horvath S, Haller RG, Lenaers G, Wallace DC, St-Onge MP, Tavazoie S, Procaccio V, Kaufman BA, Seifert EL, Hirano M, and Picard M
- Subjects
- Humans, Longevity, Mitochondria genetics, Mitochondria metabolism, DNA, Mitochondrial genetics, DNA, Mitochondrial metabolism, Oxidative Phosphorylation, Mitochondrial Diseases genetics, Mitochondrial Diseases metabolism
- Abstract
Patients with primary mitochondrial oxidative phosphorylation (OxPhos) defects present with fatigue and multi-system disorders, are often lean, and die prematurely, but the mechanistic basis for this clinical picture remains unclear. By integrating data from 17 cohorts of patients with mitochondrial diseases (n = 690) we find evidence that these disorders increase resting energy expenditure, a state termed hypermetabolism. We examine this phenomenon longitudinally in patient-derived fibroblasts from multiple donors. Genetically or pharmacologically disrupting OxPhos approximately doubles cellular energy expenditure. This cell-autonomous state of hypermetabolism occurs despite near-normal OxPhos coupling efficiency, excluding uncoupling as a general mechanism. Instead, hypermetabolism is associated with mitochondrial DNA instability, activation of the integrated stress response (ISR), and increased extracellular secretion of age-related cytokines and metabokines including GDF15. In parallel, OxPhos defects accelerate telomere erosion and epigenetic aging per cell division, consistent with evidence that excess energy expenditure accelerates biological aging. To explore potential mechanisms for these effects, we generate a longitudinal RNASeq and DNA methylation resource dataset, which reveals conserved, energetically demanding, genome-wide recalibrations. Taken together, these findings highlight the need to understand how OxPhos defects influence the energetic cost of living, and the link between hypermetabolism and aging in cells and patients with mitochondrial diseases., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
36. Commentaries on Viewpoint: Hoping for the best, prepared for the worst: can we perform remote data collection in sport sciences?
- Author
-
Louis J, Bennett S, Owens DJ, Tiollier E, Brocherie F, Carneiro MAS, Nunes PRP, Costa B, Castro-e-Souza P, Lima LA, Lisboa F, Oliveira-Júnior G, Kassiano W, Cyrino ES, Orsatti FL, Bossi, Matta G, Tolomeu de Oliveira G, Renato Melo F, Rocha Soares E, Ocelli Ungheri B, Daros Pinto M, Nuzzo JL, Latella C, van den Hoek D, Mallard A, Spathis J, DeBlauw JA, Ives SJ, Ravanelli N, Narang BJ, Debevec T, Baptista LC, Padrão AI, Oliveira J, Mota J, Zacca R, Nikolaidis PT, Lott DJ, Forbes SC, Cooke K, Taivassalo T, Elmer SJ, Durocher JJ, Fernandes RJ, Silva G, and Costa MJ
- Subjects
- Data Collection, Sports
- Published
- 2022
- Full Text
- View/download PDF
37. Integrating Mechanisms of Exacerbated Atrophy and Other Adverse Skeletal Muscle Impact in COPD.
- Author
-
Taivassalo T and Hepple RT
- Abstract
The normal decline in skeletal muscle mass that occurs with aging is exacerbated in patients with chronic obstructive pulmonary disease (COPD) and contributes to poor health outcomes, including a greater risk of death. There has been controversy about the causes of this exacerbated muscle atrophy, with considerable debate about the degree to which it reflects the very sedentary nature of COPD patients vs. being precipitated by various aspects of the COPD pathophysiology and its most frequent proximate cause, long-term smoking. Consistent with the latter view, recent evidence suggests that exacerbated aging muscle loss with COPD is likely initiated by decades of smoking-induced stress on the neuromuscular junction that predisposes patients to premature failure of muscle reinnervation capacity, accompanied by various alterations in mitochondrial function. Superimposed upon this are various aspects of COPD pathophysiology, such as hypercapnia, hypoxia, and inflammation, that can also contribute to muscle atrophy. This review will summarize the available knowledge concerning the mechanisms contributing to exacerbated aging muscle affect in COPD, consider the potential role of comorbidities using the specific example of chronic kidney disease, and identify emerging molecular mechanisms of muscle impairment, including mitochondrial permeability transition as a mechanism of muscle atrophy, and chronic activation of the aryl hydrocarbon receptor in driving COPD muscle pathophysiology., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Taivassalo and Hepple.)
- Published
- 2022
- Full Text
- View/download PDF
38. Unbiased proteomics, histochemistry, and mitochondrial DNA copy number reveal better mitochondrial health in muscle of high-functioning octogenarians.
- Author
-
Ubaida-Mohien C, Spendiff S, Lyashkov A, Moaddel R, MacMillan NJ, Filion ME, Morais JA, Taivassalo T, Ferrucci L, and Hepple RT
- Subjects
- Aged, 80 and over, Canada, DNA Copy Number Variations, Humans, Mitochondria metabolism, Muscle, Skeletal metabolism, Octogenarians, Quadriceps Muscle, DNA, Mitochondrial genetics, DNA, Mitochondrial metabolism, Proteomics
- Abstract
Background: Master athletes (MAs) prove that preserving a high level of physical function up to very late in life is possible, but the mechanisms responsible for their high function remain unclear., Methods: We performed muscle biopsies in 15 octogenarian world-class track and field MAs and 14 non-athlete age/sex-matched controls (NA) to provide insights into mechanisms for preserving function in advanced age. Muscle samples were assessed for respiratory compromised fibers, mitochondrial DNA (mtDNA) copy number, and proteomics by liquid-chromatography mass spectrometry., Results: MA exhibited markedly better performance on clinical function tests and greater cross-sectional area of the vastus lateralis muscle. Proteomics analysis revealed marked differences, where most of the ~800 differentially represented proteins in MA versus NA pertained to mitochondria structure/function such as electron transport capacity (ETC), cristae formation, mitochondrial biogenesis, and mtDNA-encoded proteins. In contrast, proteins from the spliceosome complex and nuclear pore were downregulated in MA. Consistent with proteomics data, MA had fewer respiratory compromised fibers, higher mtDNA copy number, and an increased protein ratio of the cristae-bound ETC subunits relative to the outer mitochondrial membrane protein voltage-dependent anion channel. There was a substantial overlap of proteins overrepresented in MA versus NA with proteins that decline with aging and that are higher in physically active than sedentary individuals. However, we also found 176 proteins related to mitochondria that are uniquely differentially expressed in MA., Conclusions: We conclude that high function in advanced age is associated with preserving mitochondrial structure/function proteins, with underrepresentation of proteins involved in the spliceosome and nuclear pore complex. Whereas many of these differences in MA appear related to their physical activity habits, others may reflect unique biological (e.g., gene, environment) mechanisms that preserve muscle integrity and function with aging., Funding: Funding for this study was provided by operating grants from the Canadian Institutes of Health Research (MOP 84408 to TT and MOP 125986 to RTH). This work was supported in part by the Intramural Research Program of the National Institute on Aging, NIH, Baltimore, MD, USA., Competing Interests: CU, SS, AL, RM, NM, MF, JM, TT, LF, RH No competing interests declared
- Published
- 2022
- Full Text
- View/download PDF
39. Chronic aryl hydrocarbon receptor activity phenocopies smoking-induced skeletal muscle impairment.
- Author
-
Thome T, Miguez K, Willms AJ, Burke SK, Chandran V, de Souza AR, Fitzgerald LF, Baglole C, Anagnostou ME, Bourbeau J, Jagoe RT, Morais JA, Goddard Y, Taivassalo T, Ryan TE, and Hepple RT
- Subjects
- Animals, Humans, Mice, Muscle, Skeletal metabolism, Smoke adverse effects, Smoking adverse effects, Pulmonary Disease, Chronic Obstructive genetics, Receptors, Aryl Hydrocarbon genetics, Receptors, Aryl Hydrocarbon metabolism
- Abstract
Background: Chronic obstructive pulmonary disease (COPD) patients exhibit skeletal muscle atrophy, denervation, and reduced mitochondrial oxidative capacity. Whilst chronic tobacco smoke exposure is implicated in COPD muscle impairment, the mechanisms involved are ambiguous. The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that activates detoxifying pathways with numerous exogenous ligands, including tobacco smoke. Whereas transient AHR activation is adaptive, chronic activation can be toxic. On this basis, we tested the hypothesis that chronic smoke-induced AHR activation causes adverse muscle impact., Methods: We used clinical patient muscle samples, and in vitro (C2C12 myotubes) and in vivo models (mouse), to perform gene expression, mitochondrial function, muscle and neuromuscular junction morphology, and genetic manipulations (adeno-associated virus-mediated gene transfer)., Results: Sixteen weeks of tobacco smoke exposure in mice caused muscle atrophy, neuromuscular junction degeneration, and reduced oxidative capacity. Similarly, smoke exposure reprogrammed the muscle transcriptome, with down-regulation of mitochondrial and neuromuscular junction genes. In mouse and human patient specimens, smoke exposure increased muscle AHR signalling. Mechanistically, experiments in cultured myotubes demonstrated that smoke condensate activated the AHR, caused mitochondrial impairments, and induced an AHR-dependent myotube atrophy. Finally, to isolate the role of AHR activity, expression of a constitutively active AHR mutant without smoke exposure caused atrophy and mitochondrial impairments in cultured myotubes, and muscle atrophy and neuromuscular junction degeneration in mice., Conclusions: These results establish that chronic AHR activity, as occurs in smokers, phenocopies the atrophy, mitochondrial impairment, and neuromuscular junction degeneration caused by chronic tobacco smoke exposure., (© 2021 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.)
- Published
- 2022
- Full Text
- View/download PDF
40. Postcontractile blood oxygenation level-dependent (BOLD) response in Duchenne muscular dystrophy.
- Author
-
Lopez C, Taivassalo T, Berru MG, Saavedra A, Rasmussen HC, Batra A, Arora H, Roetzheim AM, Walter GA, Vandenborne K, and Forbes SC
- Subjects
- Humans, Leg, Magnetic Resonance Imaging, Male, Muscle Contraction, Muscle, Skeletal, Muscular Dystrophy, Duchenne
- Abstract
Duchenne muscular dystrophy (DMD) is characterized by a progressive replacement of muscle by fat and fibrous tissue, muscle weakness, and loss of functional abilities. Impaired vasodilatory and blood flow responses to muscle activation have also been observed in DMD and associated with mislocalization of neuronal nitric oxide synthase mu (nNOSμ) from the sarcolemma. The objective of this study was to determine whether the postcontractile blood oxygen level-dependent (BOLD) MRI response is impaired in DMD and correlated with established markers of disease severity in DMD, including MRI muscle fat fraction (FF) and clinical functional measures. Young boys with DMD ( n = 16, 5-14 yr) and unaffected controls ( n = 16, 5-14 yr) were evaluated using postcontractile BOLD, FF, and functional assessments. The BOLD response was measured following five brief (2 s) maximal voluntary dorsiflexion contractions, each separated by 1 min of rest. FFs from the anterior compartment lower leg muscles were quantified via chemical shift-encoded imaging. Functional abilities were assessed using the 10 m walk/run and the 6-min walk distance (6MWD). The peak BOLD responses in the tibialis anterior and extensor digitorum longus were reduced ( P < 0.001) in DMD compared with controls. Furthermore, the anterior compartment peak BOLD response correlated with function (6MWD ρ = 0.87, P < 0.0001; 10 m walk/run time ρ = -0.78, P < 0.001) and FF (ρ = -0.52, P = 0.05). The reduced postcontractile BOLD response in DMD may reflect impaired microvascular function. The relationship observed between the postcontractile peak BOLD response and functional measures and FF suggests that the BOLD response is altered with disease severity in DMD. NEW & NOTEWORTHY This study examined the postcontractile blood oxygen level-dependent (BOLD) response in boys with Duchenne muscular dystrophy (DMD) and unaffected controls, and correlated this measure to markers of disease severity. Our findings indicate that the postcontractile BOLD response is impaired in DMD after brief muscle contractions, is correlated to disease severity, and may be valuable to implement in future studies to evaluate treatments targeting microvascular function in DMD.
- Published
- 2021
- Full Text
- View/download PDF
41. Safety, feasibility, and efficacy of strengthening exercise in Duchenne muscular dystrophy.
- Author
-
Lott DJ, Taivassalo T, Cooke KD, Park H, Moslemi Z, Batra A, Forbes SC, Byrne BJ, Walter GA, and Vandenborne K
- Subjects
- Child, Creatine Kinase blood, Feasibility Studies, Hamstring Muscles diagnostic imaging, Humans, Magnetic Resonance Imaging, Male, Muscle Strength, Muscle, Skeletal diagnostic imaging, Muscular Dystrophy, Duchenne blood, Muscular Dystrophy, Duchenne diagnostic imaging, Quadriceps Muscle diagnostic imaging, Treatment Outcome, Exercise, Exercise Therapy methods, Muscular Dystrophy, Duchenne rehabilitation
- Abstract
Background: This two-part study explored the safety, feasibility, and efficacy of a mild-moderate resistance isometric leg exercise program in ambulatory boys with Duchenne muscular dystrophy (DMD)., Methods: First, we used a dose escalation paradigm with varying intensity and frequency of leg isometric exercise to determine the dose response and safety in 10 boys. Second, we examined safety and feasibility of a 12-wk in-home, remotely supervised, mild-moderate intensity strengthening program in eight boys. Safety measures included T
2 MRI, creatine kinase levels, and pain. Peak strength and function (time to ascend/descend four stairs) were also measured., Results: Dose-escalation revealed no signs of muscle damage. Seven of the eight boys completed the 12-wk in-home program with a compliance of 84.9%, no signs of muscle damage, and improvements in strength (knee extensors P < .01; knee flexors P < .05) and function (descending steps P < .05)., Conclusions: An in-home, mild-moderate intensity leg exercise program is safe with potential to positively impact both strength and function in ambulatory boys with DMD., (© 2020 Wiley Periodicals LLC.)- Published
- 2021
- Full Text
- View/download PDF
42. Walking activity in a large cohort of boys with Duchenne muscular dystrophy.
- Author
-
Lott DJ, Taivassalo T, Senesac CR, Willcocks RJ, Harrington AM, Zilke K, Cunkle H, Powers C, Finanger EL, Rooney WD, Tennekoon GI, and Vandenborne K
- Subjects
- Accelerometry, Activities of Daily Living, Case-Control Studies, Child, Child, Preschool, Cohort Studies, Disease Progression, Functional Status, Glucocorticoids therapeutic use, Humans, Male, Mobility Limitation, Muscular Dystrophy, Duchenne drug therapy, Exercise, Muscular Dystrophy, Duchenne physiopathology, Walking
- Abstract
Introduction: In this study we explored walking activity in a large cohort of boys with Duchenne muscular dystrophy (DMD)., Methods: Step activity (monitored for 7 days), functional ability, and strength were quantified in ambulatory boys (5-12.9 years of age) with DMD and unaffected boys. Ambulatory status was determined 2 years later., Results: Two to 5 days of activity monitoring predicted weekly step activity (adjusted R
2 = 0.80-0.95). Age comparisons revealed significant declines for step activity with increasing age, and relationships were found between step activity with both function and strength (P < .01). Our regression model predicted 36.5% of the variance in step activity. Those who were still ambulatory after 2 years demonstrated baseline step activity nearly double that of those who were no longer walking 2 years later (P < .01)., Discussion: Step activity for DMD is related to and predictive of functional declines, which may be useful for clinical trials., (© 2020 Wiley Periodicals LLC.)- Published
- 2021
- Full Text
- View/download PDF
43. Eccentric versus conventional cycle training to improve muscle strength in advanced COPD: A randomized clinical trial.
- Author
-
Bourbeau J, De Sousa Sena R, Taivassalo T, Richard R, Jensen D, Baril J, Rocha Vieira DS, and Perrault H
- Subjects
- Aged, Exercise, Heart Rate, Humans, Male, Middle Aged, Pulmonary Disease, Chronic Obstructive physiopathology, Quadriceps Muscle, Bicycling, Dyspnea physiopathology, Exercise Therapy methods, Fatigue physiopathology, Muscle Strength, Pulmonary Disease, Chronic Obstructive rehabilitation
- Abstract
Objectives: To compare eccentric (ECC) and conventional concentric (CON) cycle training on quadriceps muscle strength in advanced COPD. Secondary objective was to assess functional capacity., Methods: A parallel-group, assessor-blind, randomized trial was conducted. Severe COPD patients were randomized to either an ECC (n = 13) or CON (n = 11) cycling program for 30-min, 3 times/week for 10 weeks. ECC group trained at ∼4-fold higher power than the CON group at similar relative heart rate intensity., Results: Isometric and isokinetic quadriceps peak torque improved after ECC but not CON; between group difference was significant for isometric peak muscle force (p < 0.05). Peak cycling power and endurance time increased in both groups (p < 0.05). Dyspnea at peak cycling power improved only after ECC training (p < 0.05). Sensory intensity ratings of dyspnea and leg fatigue were significantly lower (p < 0.05) during ECC compared with CON at equivalent relative heart rate intensities., Conclusions: ECC could be an effective alternative and/or adjunct modality to pulmonary rehabilitation in severely ventilatory limited COPD patients., Competing Interests: Declaration of Competing Interest None., (Copyright © 2020. Published by Elsevier B.V.)
- Published
- 2020
- Full Text
- View/download PDF
44. Fidelity of muscle fibre reinnervation modulates ageing muscle impact in elderly women.
- Author
-
Sonjak V, Jacob K, Morais JA, Rivera-Zengotita M, Spendiff S, Spake C, Taivassalo T, Chevalier S, and Hepple RT
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Muscular Atrophy physiopathology, Aging physiology, Muscle Fibers, Skeletal physiology
- Abstract
Key Points: Susceptibility to age-related muscle atrophy relates to the degree of muscle denervation and the capacity of successful reinnervation. However, the specific role of denervation as a determinant of the severity of muscle aging between populations with low versus high physical function has not been addressed. We show that prefrail/frail elderly women exhibited marked features of muscle denervation, whereas world class octogenarian female master athletes showed attenuated indices of denervation and greater reinnervation capacity. These findings suggest that the difference in age-related muscle impact between low- and high-functioning elderly women is the robustness of the response to denervation of myofibers., Abstract: Ageing muscle degeneration is a key contributor to physical frailty; however, the factors responsible for exacerbated vs. muted ageing muscle impact are largely unknown. Based upon evidence that susceptibility to neurogenic impact is an important determinant of the severity of ageing muscle degeneration, we aimed to determine the presence and extent of denervation in pre-frail/frail elderly (FE, 77.9 ± 6.2 years) women compared to young physically inactive (YI, 24.0 ± 3.5 years) females, and contrast these findings to high-functioning world class octogenarian female masters athletes (MA, 80.9 ± 6.6 years). Muscle biopsies from vastus lateralis muscle were obtained from all three groups to assess denervation-related morphological and transcriptional markers. The FE group displayed marked grouping of slow fibres, accumulation of very small myofibres, a severe reduction in type IIa/I size ratio, highly variable inter-subject accumulation of neural cell adhesion molecule (NCAM)-positive myofibres, and an accumulation of pyknotic nuclei, indicative of recurring cycles of denervation/reinnervation and persistent denervation. The MA group exhibited a smaller decline in type IIa/I size ratio and fewer pyknotic nuclei, accompanied by a higher degree of type I fibre grouping and larger fibre group size, suggesting a greater reinnervation of denervated fibres. Consistent with this interpretation, MA had higher mRNA levels of the reinnervation-promoting cytokine fibroblast growth factor binding protein 1 (FGFBP1) than FE. Our results indicate that the muscle of FE women has significant neurogenic atrophy, whereas MA muscle exhibit superior reinnervation capacity, suggesting that the difference in age-related muscle impact between low- and high-functioning elderly women is the robustness of the response to denervation of myofibres., (© 2019 The Authors. The Journal of Physiology © 2019 The Physiological Society.)
- Published
- 2019
- Full Text
- View/download PDF
45. Smoke-induced neuromuscular junction degeneration precedes the fibre type shift and atrophy in chronic obstructive pulmonary disease.
- Author
-
Kapchinsky S, Vuda M, Miguez K, Elkrief D, de Souza AR, Baglole CJ, Aare S, MacMillan NJ, Baril J, Rozakis P, Sonjak V, Pion C, Aubertin-Leheudre M, Morais JA, Jagoe RT, Bourbeau J, Taivassalo T, and Hepple RT
- Subjects
- Aged, Animals, Biomarkers analysis, Humans, Male, Mice, Mice, Inbred C57BL, Muscle Fibers, Skeletal metabolism, Muscular Atrophy metabolism, Muscular Atrophy pathology, Pulmonary Disease, Chronic Obstructive metabolism, Pulmonary Disease, Chronic Obstructive pathology, Smoking adverse effects, Muscle Fibers, Skeletal pathology, Muscular Atrophy etiology, Neuromuscular Junction pathology, Pulmonary Disease, Chronic Obstructive complications, Smoking physiopathology
- Abstract
Key Points: Chronic obstructive pulmonary disease (COPD) is largely caused by smoking, and patient limb muscle exhibits a fast fibre shift and atrophy. We show that this fast fibre shift is associated with type grouping, suggesting recurring cycles of denervation-reinnervation underlie the type shift. Compared to patients with normal fat-free mass index (FFMI), patients with low FFMI exhibited an exacerbated fibre type shift, marked accumulation of very small persistently denervated muscle fibres, and a blunted denervation-responsive transcript profile, suggesting failed denervation precipitates muscle atrophy in patients with low FFMI. Sixteen weeks of passive tobacco smoke exposure in mice caused neuromuscular junction degeneration, consistent with a key role for smoke exposure in initiating denervation in COPD., Abstract: A neurological basis for the fast fibre shift and atrophy seen in limb muscle of patients with chronic obstructive pulmonary disease (COPD) has not been considered previously. The objective of our study was: (1) to determine if denervation contributes to fast fibre shift and muscle atrophy in COPD; and (2) to assess using a preclinical smoking mouse model whether chronic tobacco smoke (TS) exposure could initiate denervation by causing neuromuscular junction (NMJ) degeneration. Vastus lateralis muscle biopsies were obtained from severe COPD patients [n = 10 with low fat-free mass index (FFMI), 65 years; n = 15 normal FFMI, 65 years) and healthy age- and activity-matched non-smoker control subjects (CON; n = 11, 67 years), to evaluate morphological and transcriptional markers of denervation. To evaluate the potential for chronic TS exposure to initiate these changes, we examined NMJ morphology in male adult mice following 16 weeks of passive TS exposure. We observed a high proportion of grouped fast fibres and a denervation transcript profile in COPD patients, suggesting that motor unit remodelling drives the fast fibre type shift in COPD patient limb muscle. A further exacerbation of fast fibre grouping in patients with low FFMI, coupled with blunted reinnervation signals, accumulation of very small non-specific esterase hyperactive fibres and neural cell adhesion molecule-positive type I and type II fibres, suggests denervation-induced exhaustion of reinnervation contributes to muscle atrophy in COPD. Evidence from a smoking mouse model showed significant NMJ degeneration, suggesting that recurring denervation in COPD is probably caused by decades of chronic TS exposure., (© 2018 The Authors. The Journal of Physiology © 2018 The Physiological Society.)
- Published
- 2018
- Full Text
- View/download PDF
46. Erratum to: Common data elements for clinical research in mitochondrial disease: a National Institute for Neurological Disorders and Stroke project.
- Author
-
Karaa A, Rahman S, Lombès A, Yu-Wai-Man P, Sheikh MK, Alai-Hansen S, Cohen BH, Dimmock D, Emrick L, Falk MJ, McCormack S, Mirsky D, Moore T, Parikh S, Shoffner J, Taivassalo T, Tarnopolsky M, Tein I, Odenkirchen JC, and Goldstein A
- Published
- 2018
- Full Text
- View/download PDF
47. Common data elements for clinical research in mitochondrial disease: a National Institute for Neurological Disorders and Stroke project.
- Author
-
Karaa A, Rahman S, Lombès A, Yu-Wai-Man P, Sheikh MK, Alai-Hansen S, Cohen BH, Dimmock D, Emrick L, Falk MJ, McCormack S, Mirsky D, Moore T, Parikh S, Shoffner J, Taivassalo T, Tarnopolsky M, Tein I, Odenkirchen JC, and Goldstein A
- Subjects
- Biomedical Research standards, Data Collection standards, Humans, National Institute of Neurological Disorders and Stroke (U.S.), Research Design standards, United States, Common Data Elements standards, Mitochondrial Diseases pathology, Nervous System Diseases pathology, Stroke pathology
- Abstract
Objectives: The common data elements (CDE) project was developed by the National Institute of Neurological Disorders and Stroke (NINDS) to provide clinical researchers with tools to improve data quality and allow for harmonization of data collected in different research studies. CDEs have been created for several neurological diseases; the aim of this project was to develop CDEs specifically curated for mitochondrial disease (Mito) to enhance clinical research., Methods: Nine working groups (WGs), composed of international mitochondrial disease experts, provided recommendations for Mito clinical research. They initially reviewed existing NINDS CDEs and instruments, and developed new data elements or instruments when needed. Recommendations were organized, internally reviewed by the Mito WGs, and posted online for external public comment for a period of eight weeks. The final version was again reviewed by all WGs and the NINDS CDE team prior to posting for public use., Results: The NINDS Mito CDEs and supporting documents are publicly available on the NINDS CDE website ( https://commondataelements.ninds.nih.gov/ ), organized into domain categories such as Participant/Subject Characteristics, Assessments, and Examinations., Conclusion: We developed a comprehensive set of CDE recommendations, data definitions, case report forms (CRFs), and guidelines for use in Mito clinical research. The widespread use of CDEs is intended to enhance Mito clinical research endeavors, including natural history studies, clinical trial design, and data sharing. Ongoing international collaboration will facilitate regular review, updates and online publication of Mito CDEs, and support improved consistency of data collection and reporting.
- Published
- 2017
- Full Text
- View/download PDF
48. Eccentric Ergometer Training Promotes Locomotor Muscle Strength but Not Mitochondrial Adaptation in Patients with Severe Chronic Obstructive Pulmonary Disease.
- Author
-
MacMillan NJ, Kapchinsky S, Konokhova Y, Gouspillou G, de Sousa Sena R, Jagoe RT, Baril J, Carver TE, Andersen RE, Richard R, Perrault H, Bourbeau J, Hepple RT, and Taivassalo T
- Abstract
Eccentric ergometer training (EET) is increasingly being proposed as a therapeutic strategy to improve skeletal muscle strength in various cardiorespiratory diseases, due to the principle that lengthening muscle actions lead to high force-generating capacity at low cardiopulmonary load. One clinical population that may particularly benefit from this strategy is chronic obstructive pulmonary disease (COPD), as ventilatory constraints and locomotor muscle dysfunction often limit efficacy of conventional exercise rehabilitation in patients with severe disease. While the feasibility of EET for COPD has been established, the nature and extent of adaptation within COPD muscle is unknown. The aim of this study was therefore to characterize the locomotor muscle adaptations to EET in patients with severe COPD, and compare them with adaptations gained through conventional concentric ergometer training (CET). Male patients were randomized to either EET ( n = 8) or CET ( n = 7) for 10 weeks and matched for heart rate intensity. EET patients trained on average at a workload that was three times that of CET, at a lower perception of leg fatigue and dyspnea. EET led to increases in isometric peak strength and relative thigh mass ( p < 0.01) whereas CET had no such effect. However, EET did not result in fiber hypertrophy, as morphometric analysis of muscle biopsies showed no increase in mean fiber cross-sectional area ( p = 0.82), with variability in the direction and magnitude of fiber-type responses (20% increase in Type 1, p = 0.18; 4% decrease in Type 2a, p = 0.37) compared to CET (26% increase in Type 1, p = 0.04; 15% increase in Type 2a, p = 0.09). EET had no impact on mitochondrial adaptation, as revealed by lack of change in markers of mitochondrial biogenesis, content and respiration, which contrasted to improvements ( p < 0.05) within CET muscle. While future study is needed to more definitively determine the effects of EET on fiber hypertrophy and associated underlying molecular signaling pathways in COPD locomotor muscle, our findings promote the implementation of this strategy to improve muscle strength. Furthermore, contrasting mitochondrial adaptations suggest evaluation of a sequential paradigm of eccentric followed by concentric cycling as a means of augmenting the training response and attenuating skeletal muscle dysfunction in patients with advanced COPD.
- Published
- 2017
- Full Text
- View/download PDF
49. Eccentric Exercise and the Critically Ill Patient.
- Author
-
Mitchell WK, Taivassalo T, Narici MV, and Franchi MV
- Published
- 2017
- Full Text
- View/download PDF
50. Denervation drives mitochondrial dysfunction in skeletal muscle of octogenarians.
- Author
-
Spendiff S, Vuda M, Gouspillou G, Aare S, Perez A, Morais JA, Jagoe RT, Filion ME, Glicksman R, Kapchinsky S, MacMillan NJ, Pion CH, Aubertin-Leheudre M, Hettwer S, Correa JA, Taivassalo T, and Hepple RT
- Subjects
- Adult, Aged, Aged, 80 and over, Animals, Humans, Male, Mice, Transgenic, Middle Aged, Muscle Denervation, Muscle, Skeletal metabolism, Reactive Oxygen Species metabolism, Young Adult, Mitochondria, Muscle metabolism, Muscle, Skeletal innervation
- Abstract
Key Points: Mitochondria are frequently implicated in the ageing of skeletal muscle, although the role of denervation in modulating mitochondrial function in ageing muscle is unknown. We show that increased sensitivity to apoptosis initiation occurs prior to evidence of persistent denervation and is thus a primary mitochondrial defect in ageing muscle worthy of therapeutic targeting. However, at more advanced age, mitochondrial function changes are markedly impacted by persistent sporadic myofibre denervation, suggesting the mitochondrion may be a less viable therapeutic target., Abstract: Experimental denervation modulates mitochondrial function, where changes in both reactive oxygen species (ROS) and sensitivity to permeability transition are implicated in the resultant muscle atrophy. Notably, although denervation occurs sporadically in ageing muscle, its impact on ageing muscle mitochondria is unknown. Because this information has important therapeutic implications concerning targeting the mitochondrion in ageing muscle, we examined mitochondrial function in skeletal muscle from four groups of humans, comprising two active (mean ± SD age: 23.7 ± 2.7 years and 71.2 ± 4.9 years) and two inactive groups (64.8 ± 3.1 years and 82.5 ± 4.8 years), and compared this with a murine model of sporadic denervation. We tested the hypothesis that, although some alterations of mitochondrial function in aged muscle are attributable to a primary organelle defect, mitochondrial dysfunction would be impacted by persistent denervation in advanced age. Both ageing in humans and sporadic denervation in mice increased mitochondrial sensitivity to permeability transition (humans, P = 0.004; mice, P = 0.01). To determine the contribution of sporadic denervation to mitochondrial function, we pharmacologically inhibited the denervation-induced ROS response. This reduced ROS emission by 60% (P = 0.02) in sporadically denervated mouse muscle, which is similar to that seen in humans older than 75 years (-66%, P = 0.02) but not those younger than 75 years. We conclude that an increased sensitivity to permeability transition is a primary mitochondrial defect in ageing muscle. However, at more advanced age, when muscle atrophy becomes more clinically severe, mitochondrial function changes are markedly impacted by persistent sporadic denervation, making the mitochondrion a less viable therapeutic target., (© 2016 The Authors. The Journal of Physiology © 2016 The Physiological Society.)
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.